<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NGNE
Neurogene
$
()


  • One new option listing and eighteen option delistings on July 22nd

    7/22/2024 - 08:30am
  • Neurogene to be added to Russell 3000 Index July 1

    7/1/2024 - 07:39am
  • Neurogene initiated with bullish view at BMO Capital, here's why

    6/26/2024 - 16:07pm
  • Neurogene negative reaction to competitor data 'overblown,' says William Blair

    6/20/2024 - 07:32am
  • Neurogene announces first patient dosed in high-dose cohort of NGN-401

    6/18/2024 - 09:39am
  • Neurogene initiated with bullish view at Baird, here's why

    6/10/2024 - 16:20pm
  • FDA accepts Neurogene's NGN-401 gene therapy for Rett into START Pilot program

    6/3/2024 - 07:35am
  • Taysha Gene Therapies assumed at Buy from Hold at Jefferies

    5/14/2024 - 07:51am
  • Neurogene price target lowered by $4 at H.C. Wainwright, here's why

    5/13/2024 - 06:03am
  • Neurogene reports Q1 EPS ($1.00), consensus ($1.13)

    5/10/2024 - 07:32am
  • Neurogene reports data from Phase 1/2 gene therapy clinical trial for NGN-401

    5/7/2024 - 06:24am
  • Apple upgraded, Tesla downgraded: Wall Street's top analyst calls

    4/29/2024 - 09:38am
  • Neurogene initiated with bullish view at Leerink, here's why

    4/29/2024 - 06:25am
  • William Blair starts Neurogene at Outperform into Rett syndrome data

    3/21/2024 - 07:03am
  • Neurogene initiated with bullish view at William Blair

    3/21/2024 - 05:10am
dynamic_feed Breaking News